Treatment of Bacterial Meningitis
The recommended empirical treatment for bacterial meningitis in adults is ceftriaxone 2g IV every 12 hours or cefotaxime 2g IV every 6 hours, with the addition of amoxicillin 2g IV every 4 hours in patients ≥60 years old. 1
Empirical Antibiotic Therapy
For adults under 60 years old, empirical treatment should consist of:
For adults 60 years and older, empirical treatment should include:
Add vancomycin 15-20 mg/kg IV every 12 hours OR rifampicin 600 mg twice daily if penicillin-resistant pneumococci are suspected (e.g., patient recently arrived from a country with high prevalence of resistance) 1
Pathogen-Specific Treatment
Streptococcus pneumoniae
For penicillin-sensitive pneumococci (MIC ≤0.06 mg/L):
For penicillin-resistant but cephalosporin-sensitive pneumococci:
For penicillin and cephalosporin-resistant pneumococci:
Neisseria meningitidis
- Continue ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours OR
- Switch to benzylpenicillin 2.4g IV every 4 hours 1, 2
- If not treated with ceftriaxone, add a single dose of ciprofloxacin 500 mg orally 1
- Duration: 5 days if clinical recovery is observed 1, 2
Listeria monocytogenes
- Amoxicillin 2g IV every 4 hours
- Alternative: Co-trimoxazole 10-20 mg/kg (of trimethoprim component) in four divided doses 1
- Duration: 21 days 1
Haemophilus influenzae
Special Considerations
For pediatric patients with bacterial meningitis, meropenem is FDA-approved for treatment of meningitis caused by H. influenzae, N. meningitidis, and penicillin-susceptible S. pneumoniae at a dose of 40 mg/kg (maximum 2g) every 8 hours 3
In children, combination treatment with cefotaxime (300 mg/kg per day) or ceftriaxone (100 mg/kg per day) and vancomycin (60 mg/kg per day) is recommended as first-line therapy when pneumococcal meningitis cannot be ruled out 4
Ceftriaxone should be administered intravenously over 30 minutes in adults, but over 60 minutes in neonates to reduce the risk of bilirubin encephalopathy 5
Monitoring and Follow-up
- If the patient is not improving clinically, consider:
Common Pitfalls to Avoid
- Do not delay treatment while waiting for culture results if bacterial meningitis is suspected 2
- Do not use rifampin as monotherapy due to the risk of developing resistance 2
- Do not discontinue therapy prematurely, even if clinical improvement occurs rapidly, as this may lead to relapse 2
- Do not use diluents containing calcium (e.g., Ringer's solution) to reconstitute ceftriaxone due to risk of precipitation 5
- Do not administer ceftriaxone simultaneously with calcium-containing IV solutions 5